Multiple Sclerosis Treatment|omicsgroup|Journal Of Multiple Sclerosis

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Multiple Sclerosis Treatment

Multiple Sclerosis is a highly complicated autoimmune inflammatory disorder that lacks a complete cure rather than disease modifying therapies. Journal of Multiple Sclerosis is an an upcoming journal dealing with multiple sclerosis and related research. We give foremost priority to multiple sclerosis and therapeutics as a topic of high relevance and advancements. In our editorial for inaugural issue Dr. Motamedi says “Treatments under investigation for multiple sclerosis seek to improve function, curtail attacks, or limit the progression of the underlying disease. Many treatments already in clinical trials involve drugs that are used in other diseases or medications that have not been designed specifically for multiple sclerosis. Many basic investigations seeking to understand the disease to find new treatments are underway. However, these treatments and trials for drug development need research and research needs money. Money for research can be funded by the government, NGOs, grants or donations. Commemorate National Multiple Sclerosis Day (28th of May) by seeking financial support for MS research” Mohammad Hosein Kalantar Motamedi et al., Commemorate National Multiple Sclerosis Day (28th of May): Seek Funding for Research.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021